GH Research GHRS
$17.53 −$1.03 (-5.55%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $17.53 0.00%
Open$18.32
Prev close$18.56
Day range$17.29 – $18.32
Volume299.5K
Market cap$1.20B
P/E (TTM)–
Dividend yield–
GHRS Stock News
Headlines matching GH Research or the GHRS ticker, most recent first.
- CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
- Needham Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $39 Positive
- Guggenheim Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40 Positive
- Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $40 Positive
- TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
- Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
- Wells Fargo Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $44
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $65 Negative
- RBC Capital Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
- Cantor Fitzgerald Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35 Positive
- A Quick Look at Today's Ratings for GH Research(GHRS.US), With a Forecast Between $32 to $39
- Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), MapLight Therapeutics, Inc. (MPLT) Positive
- H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)
- H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $70
No comments yet — be the first to weigh in on GHRS.
Sign in to join the discussion.